Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
This study has been completed.
Study NCT00035022   Information provided by BioCryst Pharmaceuticals
First Received: May 2, 2002   Last Updated: January 12, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial